NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,000 | 0.0% | 47 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $3,000 | +50.0% | 47 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $2,000 | -33.3% | 47 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $3,000 | -25.0% | 47 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $4,000 | -60.0% | 47 | -58.8% | 0.00% | -66.7% |
Q1 2018 | $10,000 | -61.5% | 114 | -69.4% | 0.01% | -57.1% |
Q4 2017 | $26,000 | -23.5% | 373 | 0.0% | 0.01% | -26.3% |
Q3 2017 | $34,000 | +21.4% | 373 | 0.0% | 0.02% | +11.8% |
Q2 2017 | $28,000 | – | 373 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |